Financial Personal
Biotech Nintx Raises US$ 10 Million to Advance a New Generation of Medicines Based on Brazilian Biodiversity
Startup funding includes a Series A round led by venture capital firms Pitanga, Ecoa Capital and MOV Investimentos, along with a grant from FINEP SÃO PAULO — Following a US$ 3 million seed investment in 2022, Nintx (Next Innovative Therapeutics
SÃO PAULO -- Following a US$ 3 million seed investment in 2022, Nintx (Next Innovative Therapeutics), a biotech company researching and developing treatments for multifactorial diseases using Brazil’s biodiversity, has just raised an additional US$ 10 million. Read More
